Overview
IBA RadioPharma Solutions offers integrated solutions for setting up radiopharmaceuticals production centers, including cyclotrons (Cyclone® series), radiochemistry systems (NEPTIS® and CASSY®), and turnkey facilities through IntegraLab®. The company provides services including upgrades, training through IBA Academy, and production support via Kare Portal.
Org chart
In the news
- Today marks the end of this 15ᵗʰ edition of the IBA RadioPharma Solutions Users Meeting ! 👏 Thank you to all our users for the energy and questions during the workshops that pushed the conversations further, and the special moments shared in the evenings. 👏 Thank you to our speakers for openly sharing the day-to-day expertise with IBA cyclotrons and radiosynthesizers. 👏 Thank you to our colleagues for exchanging with fellow experts and giving us a first look at what is coming next. 👏 Thanks also to our host CHU de Québec for
- 𝐁𝐞𝐡𝐢𝐧𝐝 𝐞𝐯𝐞𝐫𝐲 𝐜𝐲𝐜𝐥𝐨𝐭𝐫𝐨𝐧 𝐚𝐧𝐝 𝐫𝐚𝐝𝐢𝐨𝐜𝐡𝐞𝐦𝐢𝐬𝐭𝐫𝐲 𝐦𝐨𝐝𝐮𝐥𝐞, 𝐭𝐡𝐞𝐫𝐞 𝐢𝐬 𝐚 𝐭𝐞𝐚𝐦 𝐜𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐧𝐠 𝐨𝐧 𝐩𝐫𝐨𝐝𝐮𝐜𝐭𝐬 𝐝𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭. At EANM 2026, meet the people behind every development done on your machines. During the congress, this team will want to hear what you are producing next, so they can keep building to fit your needs. 💬"We don't measure success by technological sophistication alone. We measure it by our ability to provide reliable,
- 𝐎𝐮𝐫 𝐮𝐬𝐞𝐫𝐬 𝐯𝐢𝐬𝐢𝐭𝐞𝐝 𝐭𝐡𝐞 𝐂𝐇𝐔 𝐝𝐞 𝐐𝐮é𝐛𝐞𝐜-𝐔𝐧𝐢𝐯𝐞𝐫𝐬𝐢𝐭é 𝐋𝐚𝐯𝐚𝐥 Yesterday at the IBA Users Meeting, our users had the opportunity to visit the CHU de Québec, our host for this year’s edition. A special thank you to their team for sharing what they have built with their new 1000m² Radiopharmaceutical Sciences Laboratory, including large-scale GMP production facilities, translational radiochemistry and R&D laboratories, and a modern radiopharmacy with the first IBA Cyclone® KIUBE 300 cyclotron in
- IBA RadioPharma Solutions Users Meeting 2026 almost there! We are in the starting blocks, ready to welcome you tomorrow for the Users Meeting 2026, at the Hôtel Château Laurier, in Québec city. This year is a bit special, it’s the 30th anniversary of IBA RadioPharma Solutions Users Meeting. Our team is working closely with our host, CHU de Québec, to offer a unique sharing experience and exclusive event. Get ready to exchange, learn and discuss with fellow experts and users from around the world! #IBACommunity #PET
- 𝐄𝐀𝐍𝐌 𝟐𝟎𝟐𝟔 - 𝐰𝐞’𝐥𝐥 𝐛𝐞 𝐭𝐡𝐞𝐫𝐞! In a few weeks, our IBA experts will land in Vienna to meet you at the European Association of Nuclear Medicine (EANM) congress. 𝐖𝐡𝐲 𝐦𝐞𝐞𝐭 𝐮𝐬 𝐚𝐭 𝐄𝐀𝐍𝐌? ✅ Discover Cyclone® iKure, our latest innovation, with 3D demo and get the experts’ perspective ✅ Be the first to learn more about our new radiochemistry technology developed by the team behind NEPTIS® ✅ Discuss your radioisotopes and radiopharmaceuticals production needs and what’s next for your facility with IBA and ORA
- Congratulations to Biocline Healthcare Services Limited for reaching a major milestone with the successful rigging of their new cyclotron! This important step brings the project one phase closer to supporting the production of radiopharmaceuticals and expanding access to advanced molecular imaging for patients. A heartfelt thank you to the rigging team, our customer, and all IBA colleagues whose expertise, dedication, and teamwork made this achievement possible. #Rigging #Cyclotron #Radiopharmaceuticals #NuclearMedicine
- Let's connect at the Brazilian Congress of Nuclear Medicine! Ambrosio Moreno looks forward to discussing your production needs and sharing his expertise. Meet him in Sao Paulo, Brazil, from September 4-6. #cyclotrons #radiopharmacy #CBMN2026
- Today was the kick-off meeting for NEXUS, a new 4-year collaborative project funded by the Walloon Region, with the support of the BioWin and MecaTech clusters. Bringing together four complementary partners, two academic institutions, Université libre de Bruxelles (ULB) and Vrije Universiteit Brussel (VUB), and two industrial companies, IBA and Elysia. NEXUS aims to strengthen Belgium's position in the development of innovative Astatine-211 (At-211) based targeted alpha therapies. The project aims to develop industrial At-211
Alumni
Anthony ToffoloR&D Requirement and Compliance Engineer
Related profiles
Something wrong or missing? Send an update. Fixed within 24 hours.